Pacemaker Electrode Line Using Carbon Nanotube Wire

The patent uses carbon nanotubes as the conductor material in the electrode line. Carbon nanotubes are a composite material structure consisting of carbon atoms arranged in a cylindrical lattice, combining high electrical conductivity with exceptional mechanical strength. This replaces traditional metal conductors, simultaneously achieving both high conductivity and high mechanical strength without the trade-off present in conventional materials.

The patent changes the material parameter from metal/alloy to carbon nanotubes, fundamentally altering the physical and mechanical properties of the conductor. This parameter change enables the electrode line to achieve both high electrical conductivity and high mechanical strength, resolving the contradiction between these two properties.

The patent incorporates radioactive particles into the carbon nanotube conductor, which emit radiation that inhibits fibrotic tissue growth around the implanted electrode line. By converting the potentially harmful radiation into a beneficial anti-fibrotic effect, the patent prevents the formation of excessive scar tissue, making the electrode line easier to remove after therapy while maintaining its therapeutic function.

The patent introduces a new parameter - radioactivity - into the conductor material. This parameter change has the dual effect of maintaining electrical conductivity through the carbon nanotube structure while the radioactive emission creates a localized radiation field that prevents fibrotic tissue encapsulation, thereby facilitating future removal.